Matthew Brooks
Matthew Brooks
Managing Director at Accenture
COVID has educated us about drug development, testing, approval, administration and post launch study processes. All these steps to development clinical trials to real-world care heavily use data – generating data from various sources, analyzing them for efficacy and adverse reactions during, and post, trial. But without a solution to seamlessly manage and analyze these datasets together, the process can become manually intensive and delay the time-to-market and understanding of a drug. In this presentation, the Denodo partner will discuss how life sciences companies increasingly need to blend clinical trial and real-world data with a logical data fabric.